JCO Oncology Practice Journal

Overview

publication venue for

Compromised Outcomes in Stage IV Non???Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. OP.22.00611. 2023